Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Daniel Doorley, Ph.D.

Concepts (92)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with James Doorley's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that James Doorley has written about over time.
Minisatellite Repeats, 2 publications between 2015 and 2016, average publication date March 2016. Receptors, Dopamine D4, 2 publications between 2015 and 2016, average publication date March 2016. Sex Offenses, 1 publications between 2016 and 2016, average publication date June 2016. Suicide, Attempted, 1 publications between 2016 and 2016, average publication date June 2016. Suicidal Ideation, 2 publications between 2016 and 2017, average publication date December 2016. Emotions, 4 publications between 2016 and 2020, average publication date June 2019. Affect, 1 publications between 2020 and 2020, average publication date January 2020. Anxiety, 6 publications between 2016 and 2023, average publication date October 2020. Neurofibromatosis 1, 1 publications between 2021 and 2021, average publication date August 2021. Neurofibromatosis 2, 1 publications between 2021 and 2021, average publication date August 2021. Neurofibromatoses, 2 publications between 2021 and 2021, average publication date September 2021. Orthopedics, 1 publications between 2022 and 2022, average publication date November 2022. Opioid-Related Disorders, 3 publications between 2022 and 2024, average publication date July 2023.

To see the data from this visualization as text, click here.
Doorley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (92)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.